Publications by authors named "Ahmed Abdelrheem"
Objectives: Benefits of glucagon-like peptide-1 receptor agonists (GLP-1 RA) in kidney transplant recipients have not been adequately studied.
Methods: We retrospectively examined the effects of GLP-1RA on mortality, kidney outcomes and metabolic parameters in kidney transplant (KT) recipients with T2DM treated versus not treated with GLP-1 RA. A reference group of KT recipients not treated with GLP-1RA was used for comparison.
Introduction: The incidence of mortality late in the pandemic, particularly after widespread vaccine availability, is not well understood. Herein, we elucidate the effect of this impact of the COVID pandemic as well as risk factors for mortality during it.
Methods: The primary end point was death with a functioning graft with secondary endpoints of mortality rates in subgroups and at different time intervals during the pandemic.
Background: Mycophenolate mofetil (MMF) dose is commonly reduced after kidney transplantation (KT). This study examined MMF dosing in the first 5 years after KT to determine if a lower MMF dose impacted outcomes.
Methods: We retrospectively studied 432 recipients who underwent KT between February 2012 and February 2015 in 3 centers.
Article Synopsis
- - The study evaluated the safety and effectiveness of semaglutide, a diabetes and weight loss medication, in patients with advanced chronic kidney disease (CKD) stages 4 and 5, as well as those on dialysis, due to limited existing research in this area.
- - Data from 76 patients (mostly males with a mean age of 66.8) was analyzed over approximately five years, showing significant weight loss (avg. drop of 4.9 kg) and decreased hemoglobin A1c levels (avg. drop from 8.0% to 7.1%).
- - While 63.1% reported no adverse effects, the most common issues leading to discontinuation were nausea, vomiting,